Cissy Kityo
ID: UNCST-2021-R013663
|
A Phase 4, Open-Label, Rollover Study to Provide Continued Access to Cabotegravir Long-acting Injection and Rilpivirine Long-acting Injection to Participants Living with Human Immunodeficiency Virus Type 1 (HIV-1) Infection Who Participated in Long-Acting Combination Therapy Studies.
REFNo: HS4452ES
The secondary objective is to assess the long-term safety and tolerability of CAB LA + RPV LA by evaluating the incidence of serious adverse events (SAEs), pregnancies, adverse events (AEs) leading to discontinuation of CABLA +RPV LA, and AEs considered to be related to the study intervention.,The primary objective of the study is to provide continued CAB LA + RPV LA access to participants who were enrolled and treated with CAB LA + RPV LA in the parent studies, and who, at the time of roll-over, experience and are expected to continue to experience clinical benefit from this treatment.,
|
Uganda |
2024-08-06 17:32:50 |
2027-08-06 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
alfred bulamu
ID: UNCST-2023-R008638
|
Uganda Translational Breast Cancer Screening Research Center with Innovations in MRI and Genetic Testing.
REFNo: HS4689ES
Implementation of breast MRI with genetic testing as BC screening method for women at high risk of BC by July 2029 (Phase 6) , Continuous Trainings for radiologists, radiographers and laboratory staffs on the modern technologies of MRI and Genetic testing (phase 3 to phase 6) ,Evaluating the feasibility of screening BC using MRI and genetic testing for high risk women by December 2028 (phase 5),Large scale education of the community about BC by July 2028 (phase 3 and phase 4).,Large scale determination of the utility of genetic testing as a screening modality for BC in Uganda by perform mutational genetic analysis for women at high-risk aged19 years to 80 years by July 2028 (phase 3 and phase 4) , Large scale determination of the utility of quantitative breast MRI for screening women at high risk BC aged 19 years to 80 years by July 2028 (phase 3 and phase 4) ,Training of the users on equipment i.e. Radiologists, Radiographers and laboratory staffs by 2025 (phase 2) ,Securing and installation of lab equipment for genetic testing by 2025 (Phase 2,Securing and installation of MRI with Breast coils by July 2025 (Phase 2),To build capacity for 20 laboratory health care workers in genetic testing technologies by December 2023 (phase 1).,To build capacity for 30 radiology health professionals in modern breast Imaging with MRI by December 2023 (Phase 1),To determine the utility of quantitative breast MRI for screening women at high risk breast cancer aged 19 years to 80 years by July 2024 (phase 1),To determine the utility of genetic testing as a screening modality for BC in Uganda by perform mutational genetic analysis for women at high-risk of BC aged 19 years to 80 years, by July 2024 (phase1),To build a long-lasting infrastructure for research, clinical screening in Uganda and training using modern technologies. ,To offer improved access to Breast Cancer screening in Uganda through quantitative MRI and genetic testing research center,
|
Uganda |
2024-08-06 17:27:31 |
2027-08-06 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Edward Nahurira
ID: UNCST-2022-R009739
|
Comparative Phytochemical Studies of Callus Regenerated from Leaf Explant of Prunus Africana (Hook F. Kalkman) and Stem Bark of the Same Mother Plant
REFNo: HS2434ES
1. To develop callus culture from the explant of P. africana leaf and stem bark.
2. To evaluate the phytochemical constituents of the callus extracts of P. africana leaf and stem bark explant.
3. To develop and compare the TLC and HPLC fingerprints of each extract for their identification.
|
Uganda |
2024-08-06 17:22:37 |
2027-08-06 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
ANITA ARINDA
ID: UNCST-2020-R014158
|
Intellectual Disability in Children and Adolescents with Epilepsy in Mulago and Butabika National Referral Hospitals: Prevalence and Associated Factors
REFNo: HS4589ES
2. To determine the factors associated with ID in children and adolescents with epilepsy attending Mulago and Butabika National Referral Hospitals.,1. To determine the prevalence of ID in children and adolescents with epilepsy attending Mulago and Butabika National Referral Hospitals.,To determine the prevalence of and factors associated with ID in children and adolescents with epilepsy attending Mulago and Butabika National Referral Hospitals.,
|
Uganda |
2024-08-05 14:04:37 |
2027-08-05 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Moses Oketch
ID: UNCST-2024-R004313
|
Long-Term Impacts of Improved Childhood Literacy
REFNo: SS2796ES
Economic situation,
|
UK |
2024-08-05 14:01:33 |
2027-08-05 |
Social Science and Humanities |
Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|